Autolus Therapeutics plc
AUTL· Nasdaq
AUTLAutolus Therapeutics plc
Quarterly figures for Autolus Therapeutics plc, with source filings when available.
29 quarters. Jun 30, 2018 to Jun 30, 2026. USD.
Autolus Therapeutics plc has filed its 10-Q within 38 to 47 days of period end across its last 8 quarters. The 10-K runs 79 to 86 days.
Autolus Therapeutics plc · CIK 1730463 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 11, 2026 · pre-market | Aug 11, 2026 | 42 d | 10-Q | $45.69M | +118.4% | -$0.15 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 14, 2026 · pre-market |
| May 14, 2026 |
| 44 d |
| 10-Q |
| $26.22M |
| +191.9% |
| -$0.27 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 27, 2026 · pre-market | Mar 27, 2026 | 86 d | 10-K | $24.29M | +83,655.2% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 · pre-market | Nov 12, 2025 | 43 d | 10-Q | $21.19M | — | -$0.30 | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · pre-market | Aug 12, 2025 | 43 d | 10-Q | $20.92M | — | -$0.18 | |
| Q1 2025 | Mar 31, 2025 | May 8, 2025 · pre-market | May 8, 2025 | 38 d | 10-Q | $8.98M | −11.0% | -$0.26 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 20, 2025 · pre-market | Mar 20, 2025 | 79 d | 10-K | $29.00K | — | — | |
| Q3 2024 | Sep 30, 2024 | Nov 12, 2024 · pre-market | Nov 12, 2024 | 43 d | 10-Q | $0.00 | — | -$0.31 | |
| Q2 2024 | Jun 30, 2024 | Aug 8, 2024 · pre-market | Aug 8, 2024 | 39 d | 10-Q | $0.00 | — | -$0.22 | |
| Q1 2024 | Mar 31, 2024 | May 17, 2024 · pre-market | May 17, 2024 | 47 d | 10-Q | $10.09M | — | -$0.24 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 14, 2024 · market hours | Mar 21, 2024 | 81 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 9, 2023 | 40 d | 10-Q | — | — | -$0.26 | |
| Q2 2023 | Jun 30, 2023 | — | — | — | — | — | — | -$0.26 | |
| Q1 2023 | Mar 31, 2023 | — | — | — | — | — | — | -$0.23 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | — | — | — | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | — | — | — | — | — | -$0.47 | |
| Q2 2022 | Jun 30, 2022 | — | — | — | — | — | — | -$0.46 | |
| Q1 2022 | Mar 31, 2022 | — | — | — | — | — | — | -$0.41 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q1 2021 | Mar 31, 2021 | — | — | — | — | $269.00K | −20.4% | -$0.53 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | — | — | -$0.72 | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $293.00K | −13.3% | -$0.62 | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | $338.00K | — | -$0.60 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | — | — | — | $309.00K | +4.4% | — | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | $297.00K | −3.3% | -$0.61 | |
| Q2 2019 | Jun 30, 2019 | — | — | — | — | $338.00K | −23.7% | -$0.65 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | — | — | — | — | $296.00K | — | -$0.52 | |
| Q3 2018 | Sep 30, 2018 | — | — | — | — | $307.00K | — | -$0.33 | |
| Q2 2018 | Jun 30, 2018 | — | — | — | — | $443.00K | — | -$0.26 | |
